Predictive In-Vitro Evaluation of Food Effect on The In-Vivo Performance of Chlorpropamide Tablet
This study compared the disintegration time and dissolution profile of the hypoglyceamic drug product, chlorpropamide marketed in Nigeria as Chlorbinese in simulated gastric fluid (SGF), simulated intestinal fluid SIF, and in food modified gastric fluid (FMSGF) and intestinal fluid (FMSIF) as a measure of the effect of dosing condition on in-vivo drug performance.
Various quality control parameters including weight uniformity, tablet hardness, disintegration, friability and assay were assessed prior the dissolution profile determination. Food containing media was prepared by blending 1.3ml full cream fat containing milk and 25mg of soluble starch Â added to 500ml and 300ml of SGF and SIF to make FMSGF and FMSIF respectively, mimicking human gastric and intestinal content after drug administration. The in-vivo performance of the drug at the dosing conditions was also determined using 24 healthy volunteers with post dosing administration of drug and blood sampling at time intervals.
The titrimetric and spectrophotometric assays gave 99.37% and 104.12% of chlorpropamide content respectively (P<0.05). No significant differences were observed between the disintegration time for FMSGF, SGF, SIF and FMSIF being (5s, 4s ,4s and 6s) respectively at P<0.05. There was no significant difference in the percentage drug release in FMSIF compared with SIF (40% v 35%) similarly there was Â no difference in the release rate for media simulating dosing conditions in the stomach revealing (28% v 28%) release at P<0.05. There was no significant difference in the change in blood glucose level in the volunteers with respect to the dosing conditions P<0.05.Dosing conditions did not affect the drug release and blood glucose reduction of chlorpropamide tablet.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).